The UK-US deal does not resolve every challenge – no single agreement could. But it marks a meaningful step toward restoring ...

The recommendation by the CHMP should now result in approval of Arexvy in the broader age range in February next year, and ...

Blood is a rich source for biomarker development, and CTCs are increasingly proving themselves to be valuable in cancer ...

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) and Singaporean Health Sciences Authority (HSA) say the ...

Drug delivery is no longer just about convenience. It’s about enabling the therapies of the future to succeed where they ...

RNA interference drug developer SanegeneBio leads our round-up of this week's biotech financings, with a $110 million Series ...

Flow Neuroscience has secured FDA approval for its at-home brain stimulation device, the FL-100 wearable device, as a ...

Chambers discusses her personal experience as a GP in the NHS, including the discrimination she faced as a woman, and ...

Today, the EU Council and Parliament reached an agreement in principle on the long-awaited pharma reform package, but ...

Artificial intelligence (AI) is reshaping industries across the board, but nowhere are the stakes higher than in life ...

In September, Takeda announced that it is making pharma history – becoming the first in the industry to ship medicines across ...

Menopause is another major area. “Many women can’t tolerate oral progesterone. If they’re on oestrogen and have a uterus, ...